Investing in Fennec Pharmaceuticals (NASDAQ:FENC) five years ago would have delivered you a 38% gain
The main point of investing for the long term is to make money. But more than that, you probably want to see it ...
ETF Daily News6d
Fennec Pharmaceuticals (FENC) to Release Earnings on Monday
A number of research analysts recently issued reports on FENC shares. Stephens upgraded Fennec Pharmaceuticals to a “strong-buy” rating in a research report on Monday, November 18th.